N/A
Completed N=309
CARE-HF Long Term Follow-up
Source: ClinicalTrials.gov NCT00318357 ↗Enrolled (actual)
309
Serious AEs
—
Results posted
Jun 2019
Primary outcomePrimary: All Cause Mortality — 54.8; 64.8 percentage of participants — p=0.007
Summary
The CARE-HF long-term follow-up trial evaluates the effects of cardiac resynchronization (CR) therapy on the mortality of patients from the CARE-HF program for an additional 4 year follow-up. Investigators are free to choose whatever available treatment they believe is in the patient's best interest.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY All Cause Mortality |
54.8; 64.8 | 0.007 sig |
Eligibility Criteria
Inclusion Criteria
- Patients who have participated in the CARE-HF program and were reported to be alive in May 2005
- Patients who signed a patient data release consent form
Exclusion Criteria
- Patients who have not participated in the CARE-HF program
- Patients with exclusion criteria required by local legislation
Data sourced from ClinicalTrials.gov (NCT00318357). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.